These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32763273)

  • 21. Limited Resection Is Associated With a Higher Risk of Locoregional Recurrence than Lobectomy in Stage I Lung Adenocarcinoma With Tumor Spread Through Air Spaces.
    Kadota K; Kushida Y; Kagawa S; Ishikawa R; Ibuki E; Inoue K; Go T; Yokomise H; Ishii T; Kadowaki N; Haba R
    Am J Surg Pathol; 2019 Aug; 43(8):1033-1041. PubMed ID: 31107717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spread through air spaces is a predictive factor of recurrence and a prognostic factor in stage I lung adenocarcinoma.
    Shiono S; Yanagawa N
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):567-72. PubMed ID: 27354463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma.
    Fan CC; Cheng WC; Huang YC; Sher YP; Liou NJ; Chien YC; Lin PS; Lin PS; Chen CH; Chang WC
    Sci Rep; 2017 Nov; 7(1):14617. PubMed ID: 29097801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary Component.
    Kishi N; Ito M; Miyata Y; Kanai A; Handa Y; Tsutani Y; Kushitani K; Takeshima Y; Okada M
    Ann Surg Oncol; 2020 Mar; 27(3):945-955. PubMed ID: 31732945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk stratification for distant recurrence of resected early stage non-small cell lung cancer is under construction.
    Lanuti M
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1225-1226. PubMed ID: 29305028
    [No Abstract]   [Full Text] [Related]  

  • 26. Early brain recurrences are potentially detectable in asymptomatic, early stage lung adenocarcinoma.
    Nelson JS; Allen LD; Parker LA; Hayward MC; Zhao N; Hayes DN
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):718-20. PubMed ID: 21945387
    [No Abstract]   [Full Text] [Related]  

  • 27. Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence.
    Isaksson S; George AM; Jönsson M; Cirenajwis H; Jönsson P; Bendahl PO; Brunnström H; Staaf J; Saal LH; Planck M
    Acta Oncol; 2019 Aug; 58(8):1079-1086. PubMed ID: 31230502
    [No Abstract]   [Full Text] [Related]  

  • 28. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.
    Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
    Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
    Zengin T; Önal-Süzek T
    BMC Bioinformatics; 2020 Sep; 21(Suppl 14):368. PubMed ID: 32998690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrence Pattern of Pathologic Stage I Lung Adenocarcinoma With Visceral Pleural Invasion.
    Jiwangga D; Cho S; Kim K; Jheon S
    Ann Thorac Surg; 2017 Apr; 103(4):1126-1131. PubMed ID: 27993377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-recurrence survival analysis of stage I non-small-cell lung cancer.
    Lee K; Kim HR; Kim DK; Kim YH; Park SI; Choi SH; Han J
    Asian Cardiovasc Thorac Ann; 2017 Nov; 25(9):623-629. PubMed ID: 29058973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
    Dong M; Yang Z; Li X; Zhang Z; Yin A
    Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
    Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J
    Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
    Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
    Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma.
    Sim J; Kim Y; Kim H; Shin SJ; Kim DH; Paik SS; Jang K
    Medicine (Baltimore); 2018 Jun; 97(25):e10996. PubMed ID: 29923982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of proteins expressed differently among surgically resected stage I lung adenocarcinomas.
    Ha ES; Choi S; In KH; Lee SH; Lee EJ; Lee SY; Kim JH; Shin C; Shim JJ; Kang KH; Phark S; Sul D
    Clin Biochem; 2013 Mar; 46(4-5):369-77. PubMed ID: 23200884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classification of different patterns of pulmonary adenocarcinomas.
    Truini A; Santos Pereira P; Cavazza A; Spagnolo P; Nosseir S; Longo L; Jukna A; Lococo F; Vincenzi G; Bogina G; Tiseo M; Rossi G
    Expert Rev Respir Med; 2015 Oct; 9(5):571-86. PubMed ID: 26313326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Genes Associated with Lung Adenocarcinoma Prognosis.
    He ZH; Lv W; Wang LM; Wang YQ; Hu J
    Comb Chem High Throughput Screen; 2019; 22(4):220-224. PubMed ID: 30947660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
    Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
    Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.